Chronic myeloid leukaemia trials in New Zealand

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)

  Where

  Auckland, Christchurch

  Age

  18 years to 64 years

  People

  330 worldwide

  Run by

  Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

  See details and how to joinNCT06163430 · EU 2023-507677-18-00
• Phase 1/2Taking people
  Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

  Where

  Grafton

  Age

  18 years and over

  People

  240 worldwide

  Run by

  Aptose Biosciences Inc.

  See details and how to joinNCT03850574 · EU 2023-503244-14-00